Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Publication | Closed Access

DOI

1.2K

Citations

References

2010

Year

Luca Gianni, W. Eiermann, Alexey Manikhas, Aňa Lluch, S. Tjulandin, Milvia Zambetti, Federico Vázquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Ángel Climent,

The Lancet

Noah TrialBreast OncologyOncologyClinical TrialsBreast CancerCancer TreatmentMedicineRadiation OncologyNeoadjuvant ChemotherapyHealth Sciences